MEI Pharma Inc. (MEIP)
NASDAQ: MEIP
· Real-Time Price · USD
4.59
-0.09 (-1.92%)
At close: Aug 20, 2025, 3:59 PM
4.63
0.86%
Pre-market: Aug 21, 2025, 08:19 AM EDT
MEI Pharma Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | n/a | n/a | n/a | 65.3M | 66.75M | 72.65M | 105.38M | 48.82M | 58.77M | 62.57M | 48.06M | 52.72M | 51.42M | 44.14M | 35.09M | 25.54M | 40.92M | 39.75M | 31.59M |
Cost of Revenue | 3.78M | 3.86M | 3.95M | 4.41M | 1.09M | 1.47M | 1.83M | 1.37M | 1.26M | 804K | 358K | 358K | n/a | 405K | 899K | 1.41M | 1.89M | 2.35M | 2.49M |
Gross Profit | -3.78M | -3.86M | -3.95M | 60.89M | 65.66M | 71.18M | 103.56M | 47.45M | 57.51M | 61.77M | 47.7M | 52.36M | 51.42M | 43.74M | 34.19M | 24.13M | 39.03M | 37.4M | 29.1M |
Operating Income | -33.56M | -40.61M | -49.09M | 14.54M | 22.44M | 15.88M | 36.74M | -326K | -5.44M | -10.61M | -30.77M | -63.46M | -60.08M | -60.61M | -68.57M | -69.69M | -44.24M | -34.59M | -27.5M |
Interest Income | 1.24M | 1.95M | 2.54M | 3.28M | 3.73M | 3.98M | 3.96M | 3.35M | 2.49M | 1.59M | 757K | 285K | 92K | 90K | 243K | 510K | 818K | 1.14M | 1.3M |
Pretax Income | -31.66M | -38.22M | -46.6M | 17.78M | 26.16M | 19.84M | 41.16M | -31.84M | -37.87M | -31.16M | -47.18M | -42.43M | -32.08M | -54.67M | -60.35M | -50.57M | -63.33M | -36.35M | -45.11M |
Net Income | -31.66M | -38.22M | -46.6M | 17.77M | 26.15M | 19.84M | 41.15M | -31.84M | -37.87M | -31.16M | -53.57M | -54.46M | -46.78M | -63.67M | -59.54M | -41.32M | -52.57M | -31.28M | -43.47M |
Selling & General & Admin | 14.87M | 16.99M | 21.78M | 23.12M | 28.95M | 31.61M | 32.17M | 33.13M | 28.93M | 30.69M | 30.12M | 30.54M | 31.4M | 28.68M | 26.41M | 24.41M | 22.31M | 19.96M | 18.5M |
Research & Development | 7.78M | 12.63M | 16.24M | 16.56M | 15.19M | 25.07M | 36.47M | 52.45M | 71.72M | 78.93M | 85.15M | 85.64M | 80.1M | 75.66M | 76.36M | 69.4M | 60.96M | 52.04M | 38.1M |
Other Expenses | 10.9M | 10.89M | 10.89M | 10.89M | -19K | -19K | -21K | -22K | -10K | -6K | -2K | n/a | 4K | -9K | -9K | -14K | -18K | -5K | 8K |
Operating Expenses | 22.53M | 29.5M | 37.9M | 39.56M | 44.14M | 56.68M | 68.65M | 85.58M | 100.65M | 109.62M | 115.27M | 116.18M | 111.5M | 104.35M | 102.76M | 93.81M | 83.27M | 72M | 56.6M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -86K | -171K | -171K | -171K | -85K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 30.78M | 40.61M | 49.09M | 50.76M | 44.31M | 56.77M | 68.65M | 85.58M | 100.65M | 109.62M | 115.27M | 116.18M | 111.5M | 104.75M | 103.66M | 95.22M | 85.16M | 74.34M | 59.09M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.6M | -1.6M | -1.6M | -7.07M | -8.06M | -15.16M | -5.94M | -7.72M | -18.62M | 19.58M | 10.37M | 17.61M |
Shares Outstanding (Basic) | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.65M | 6.34M | 5.63M | 5.63M | 5.63M | 5.63M | 5.62M |
Shares Outstanding (Diluted) | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.65M | 6.41M | 5.7M | 5.8M | 5.63M | 5.72M | 5.75M |
EPS (Basic) | -4.75 | -5.73 | -6.99 | 2.67 | 3.92 | 2.97 | 6.17 | -4.78 | -5.71 | -4.7 | -8.24 | -8.95 | -8.11 | -11.4 | -10.8 | -7.4 | -9.8 | -6 | -9.8 |
EPS (Diluted) | -4.75 | -5.73 | -6.99 | 2.67 | 3.92 | 2.97 | 6.17 | -4.78 | -5.68 | -4.67 | -9.01 | -10.12 | -10.31 | -13.6 | -13.4 | -12 | -13.4 | -9.6 | -12.2 |
EBITDA | -22.31M | -29.28M | -37.76M | 25.87M | 24.04M | 17.39M | 38.25M | -35.15M | -41.7M | -46.86M | -73.34M | -75.25M | -71.88M | -66.64M | -64.79M | -57.48M | -32.08M | -28.17M | -24.55M |
EBIT | -19.88M | -29.71M | -38.19M | 26.53M | 23.54M | 16.97M | 39.16M | -35.44M | -40.55M | -45.72M | -73.6M | -75.48M | -72.1M | -66.94M | -65.08M | -57.76M | -32.31M | -28.36M | -24.7M |
Depreciation & Amortization | 493K | 579K | 664K | 755K | 1.09M | 1.47M | 1.83M | 1.47M | 1.15M | -12.08M | -12.45M | -12.47M | -12.55M | 294K | 293K | 285K | 234K | 192K | 147K |